BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16099246)

  • 1. Role of stereotactic radiosurgery as a primary treatment option in the management of newly diagnosed multiple (3-6) intracranial metastases.
    Jawahar A; Shaya M; Campbell P; Ampil F; Willis BK; Smith D; Nanda A
    Surg Neurol; 2005 Sep; 64(3):207-12. PubMed ID: 16099246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosurgery for brain metastases from primary lung carcinoma.
    Hoffman R; Sneed PK; McDermott MW; Chang S; Lamborn KR; Park E; Wara WM; Larson DA
    Cancer J; 2001; 7(2):121-31. PubMed ID: 11324765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of prognostic factors for patients with single brain metastasis treated with stereotactic radiosurgery.
    Fernandez-Vicioso E; Suh JH; Kupelian PA; Sohn JW; Barnett GH
    Radiat Oncol Investig; 1997; 5(1):31-7. PubMed ID: 9303054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma knife radiosurgery in the management of malignant melanoma brain metastases.
    Mathieu D; Kondziolka D; Cooper PB; Flickinger JC; Niranjan A; Agarwala S; Kirkwood J; Lunsford LD
    Neurosurgery; 2007 Mar; 60(3):471-81; discussion 481-2. PubMed ID: 17327791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma.
    Hara W; Tran P; Li G; Su Z; Puataweepong P; Adler JR; Soltys SG; Chang SD; Gibbs IC
    Neurosurgery; 2009 Feb; 64(2 Suppl):A26-32. PubMed ID: 19165071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survivors after gamma knife radiosurgery for brain metastases.
    Kondziolka D; Martin JJ; Flickinger JC; Friedland DM; Brufsky AM; Baar J; Agarwala S; Kirkwood JM; Lunsford LD
    Cancer; 2005 Dec; 104(12):2784-91. PubMed ID: 16288488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiosurgery in patients with multiple brain metastases.
    Chang SD; Lee E; Sakamoto GT; Brown NP; Adler JR
    Neurosurg Focus; 2000 Aug; 9(2):e3. PubMed ID: 16836289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for survival after stereotactic radiosurgery vary with the number of cerebral metastases.
    DiLuna ML; King JT; Knisely JP; Chiang VL
    Cancer; 2007 Jan; 109(1):135-45. PubMed ID: 17133440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome after radiosurgery for brain metastases in patients with low Karnofsky performance scale (KPS) scores.
    Chernov MF; Nakaya K; Izawa M; Hayashi M; Usuba Y; Kato K; Muragaki Y; Iseki H; Hori T; Takakura K
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1492-8. PubMed ID: 17276617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.
    Mehta MP; Tsao MN; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):37-46. PubMed ID: 16111570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linear accelerator stereotactic radiosurgery for metastatic brain tumors: 17 years of experience at the University of Florida.
    Swinson BM; Friedman WA
    Neurosurgery; 2008 May; 62(5):1018-31; discussion 1031-2. PubMed ID: 18580799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397).
    Manon R; O'Neill A; Knisely J; Werner-Wasik M; Lazarus HM; Wagner H; Gilbert M; Mehta M;
    J Clin Oncol; 2005 Dec; 23(34):8870-6. PubMed ID: 16314647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery.
    Chang EL; Selek U; Hassenbusch SJ; Maor MH; Allen PK; Mahajan A; Sawaya R; Woo SY
    Neurosurgery; 2005 May; 56(5):936-45; discussion 936-45. PubMed ID: 15854241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).
    Samlowski WE; Watson GA; Wang M; Rao G; Klimo P; Boucher K; Shrieve DC; Jensen RL
    Cancer; 2007 May; 109(9):1855-62. PubMed ID: 17351953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frameless stereotactic radiosurgery with a bite-plate: our experience with brain metastases.
    Furuse M; Aoki T; Takagi T; Takahashi JA; Ishikawa M
    Minim Invasive Neurosurg; 2008 Dec; 51(6):333-5. PubMed ID: 19061143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic factors for brain metastatic tumors treated with stereotactic radiosurgery].
    Xu BH; Han L; Lin SJ; Touboul E
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1425-8. PubMed ID: 16305972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cyberknife radiosurgery/radiotherapy for brain metastases of multiple or large-size tumors.
    Nishizaki T; Saito K; Jimi Y; Harada N; Kajiwara K; Nomura S; Ishihara H; Yoshikawa K; Yoneda H; Suzuki M; Gibbs IC
    Minim Invasive Neurosurg; 2006 Aug; 49(4):203-9. PubMed ID: 17041830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.
    Hu C; Chang EL; Hassenbusch SJ; Allen PK; Woo SY; Mahajan A; Komaki R; Liao Z
    Cancer; 2006 May; 106(9):1998-2004. PubMed ID: 16572401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery.
    Samlowski WE; Majer M; Boucher KM; Shrieve AF; Dechet C; Jensen RL; Shrieve DC
    Cancer; 2008 Nov; 113(9):2539-48. PubMed ID: 18780316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.